Novel pyrrhocoricin-derived peptides, and methods of use thereof
CA 2375502 A1 · Owner: The Wistar Institute Of Anatomy & Biology · Inventors: Otvos, Laszlo Jr.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Modifications of the peptide pyrrhocoricin permit the production of a variety of anti-bacterial or anti-fungal peptides having general formula R1-Asp-Lys- Gly-X-Y-Leu-Pro-Arg-Pro-Thr-Pro-Pro-Arg-Pro-Ile-Tyr-X'-Y'-R2SEQ ID NO:1 or multimeric compositions containing more than a single peptide of that formula. These peptides may be straight chain or cyclic peptides and may contain one , or more non-cleavable bonds. These peptides are characterized by antibacterial or anti-fungal activity and metabolic stability in mammalian serum. These peptides are useful in anti-bacterial or anti-fungal pharmaceutical compositions and for further drug development or identification of other antibiotic …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 21, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 21, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 21, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.